{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T16:06:22Z","timestamp":1777133182824,"version":"3.51.4"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2022,3,8]],"date-time":"2022-03-08T00:00:00Z","timestamp":1646697600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,3,8]],"date-time":"2022-03-08T00:00:00Z","timestamp":1646697600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Universit\u00e4tsklinikum RWTH Aachen"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurocrit Care"],"published-print":{"date-parts":[[2022,6]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Delayed cerebral ischemia (DCI) is a common complication of aneurysmal subarachnoid hemorrhage and contributes to unfavorable outcome. In patients with deterioration despite prophylactic nimodipine treatment, induced hypertension (iHTN) can be considered, although the safety and efficacy of induction are still a matter of debate. In this study, two iHTN treatment algorithms were compared with different approaches toward setting pressure targets.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>In a cohort of 325 consecutive patients with subarachnoid hemorrhage, 139 patients were treated by induced hypertension as a first tier treatment. On diagnosing DCI, blood pressure was raised via norepinephrine infusion in 20-mm Hg increments in 37 patients (iHTN<jats:sub>incr<\/jats:sub>), whereas 102 patients were treated by immediate elevation to systolic pressure above 180\u00a0mm Hg (iHTN<jats:sub>imm<\/jats:sub>). Treatment choice was based on personal preference of the treating physician but with a gradual shift away from incremental elevation. Both groups were evaluated for DCI-caused infarction, the need of additional endovascular rescue treatment, the occurrence of pressor-treatment-related complications, and clinical outcome assessed by the extended Glasgow outcome scale after 12\u00a0months.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The rate of refractory DCI requiring additional rescue therapy was comparable in both groups (48.9% in iHTN<jats:sub>incr<\/jats:sub>, 40.0% in iHTN<jats:sub>imm<\/jats:sub>; <jats:italic>p<\/jats:italic>\u2009=\u20090.332). The type of induced hypertension was not independently associated with the occurrence of DCI-related infarction in a logistic regression model (odds ratio 1.004; 95% confidence interval 0.329\u20133.443; <jats:italic>p<\/jats:italic>\u2009=\u20090.942). Similar rates of pressor-treatment-related complications were observed in both treatment groups. Favorable outcome was reached in 44 (43.1%) patients in the immediate vs. 10 (27.0%) patients in the incremental treatment group (<jats:italic>p<\/jats:italic>\u2009=\u20090.076). However, only Hunt and Hess grading was identified as an independent predictor variable of clinical outcome (odds ratio 0.422; 95% confidence interval 0.216\u20130.824; <jats:italic>p<\/jats:italic>\u2009=\u20090.012).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Immediate induction of hypertension with higher pressure targets did not result in a lower rate of DCI-related infarctions but was not associated with a higher complication rate compared with an incremental approach. Future tailored blood pressure management based on patient- and time-point-specific needs will hopefully better balance the neurological advantages versus the systemic complications of induced hypertension.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s12028-022-01466-7","type":"journal-article","created":{"date-parts":[[2022,3,8]],"date-time":"2022-03-08T23:02:22Z","timestamp":1646780542000},"page":"702-714","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Incremental Versus Immediate Induction of Hypertension in the Treatment of Delayed Cerebral Ischemia After Subarachnoid Hemorrhage"],"prefix":"10.1007","volume":"36","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3648-6842","authenticated-orcid":false,"given":"Michael","family":"Veldeman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miriam","family":"Weiss","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Walid","family":"Albanna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Omid","family":"Nikoubashman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henna","family":"Schulze-Steinen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hans","family":"Clusmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anke","family":"Hoellig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerrit Alexander","family":"Schubert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,3,8]]},"reference":[{"key":"1466_CR1","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/S1474-4422(11)70017-5","volume":"10","author":"GJ Rinkel","year":"2011","unstructured":"Rinkel GJ, Algra A. Long-term outcomes of patients with aneurysmal subarachnoid haemorrhage. Lancet Neurol. 2011;10:349\u201356.","journal-title":"Lancet Neurol"},{"key":"1466_CR2","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1136\/jnnp.2007.117655","volume":"78","author":"NK de Rooij","year":"2007","unstructured":"de Rooij NK, Linn FH, van der Plas JA, Algra A, Rinkel GJ. Incidence of subarachnoid haemorrhage: a systematic review with emphasis on region, age, gender and time trends. J Neurol Neurosurg Psychiatry. 2007;78:1365\u201372.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1466_CR3","doi-asserted-by":"publisher","first-page":"2918","DOI":"10.1161\/STROKEAHA.110.586826","volume":"41","author":"R Dodel","year":"2010","unstructured":"Dodel R, Winter Y, Ringel F, et al. Cost of illness in subarachnoid hemorrhage: a German longitudinal study. Stroke. 2010;41:2918\u201323.","journal-title":"Stroke"},{"key":"1466_CR4","doi-asserted-by":"publisher","first-page":"2391","DOI":"10.1161\/STROKEAHA.110.589275","volume":"41","author":"MD Vergouwen","year":"2010","unstructured":"Vergouwen MD, Vermeulen M, van Gijn J, et al. Definition of delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage as an outcome event in clinical trials and observational studies: proposal of a multidisciplinary research group. Stroke. 2010;41:2391\u20135.","journal-title":"Stroke"},{"key":"1466_CR5","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1007\/s11910-019-0990-3","volume":"19","author":"V Rass","year":"2019","unstructured":"Rass V, Helbok R. Early brain injury after poor-grade subarachnoid hemorrhage. Curr Neurol Neurosci Rep. 2019;19:78.","journal-title":"Curr Neurol Neurosci Rep"},{"key":"1466_CR6","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1007\/s12975-014-0323-4","volume":"5","author":"MK Tso","year":"2014","unstructured":"Tso MK, Macdonald RL. Subarachnoid hemorrhage: a review of experimental studies on the microcirculation and the neurovascular unit. Transl Stroke Res. 2014;5:174\u201389.","journal-title":"Transl Stroke Res"},{"key":"1466_CR7","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1177\/0271678X15621253","volume":"37","author":"M Balbi","year":"2017","unstructured":"Balbi M, Koide M, Schwarzmaier SM, Wellman GC, Plesnila N. Acute changes in neurovascular reactivity after subarachnoid hemorrhage in vivo. J Cereb Blood Flow Metab. 2017;37:178\u201387.","journal-title":"J Cereb Blood Flow Metab"},{"key":"1466_CR8","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.3171\/2020.3.JNS20375","volume":"134","author":"M Veldeman","year":"2020","unstructured":"Veldeman M, Albanna W, Weiss M, et al. Invasive neuromonitoring with an extended definition of delayed cerebral ischemia is associated with improved outcome after poor-grade subarachnoid hemorrhage. J Neurosurg. 2020;134:1527\u201334.","journal-title":"J Neurosurg"},{"key":"1466_CR9","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1007\/s12028-020-01169-x","volume":"35","author":"M Veldeman","year":"2020","unstructured":"Veldeman M, Albanna W, Weiss M, et al. Treatment of Delayed Cerebral Ischemia in Good-Grade Subarachnoid Hemorrhage: Any Role for Invasive Neuromonitoring? Neurocrit Care. 2020;35:172\u201383.","journal-title":"Neurocrit Care"},{"key":"1466_CR10","doi-asserted-by":"publisher","first-page":"R23","DOI":"10.1186\/cc8886","volume":"14","author":"JW Dankbaar","year":"2010","unstructured":"Dankbaar JW, Slooter AJ, Rinkel GJ, Schaaf IC. Effect of different components of triple-H therapy on cerebral perfusion in patients with aneurysmal subarachnoid haemorrhage: a systematic review. Crit Care. 2010;14:R23.","journal-title":"Crit Care"},{"key":"1466_CR11","first-page":"994","volume":"40","author":"JB Bederson","year":"2009","unstructured":"Bederson JB, Connolly ES Jr, Batjer HH, et al. Guidelines for the management of aneurysmal subarachnoid hemorrhage: a statement for healthcare professionals from a special writing group of the Stroke Council. Am Heart Assoc Stroke. 2009;40:994\u20131025.","journal-title":"Am Heart Assoc Stroke"},{"key":"1466_CR12","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1007\/s12028-011-9605-9","volume":"15","author":"MN Diringer","year":"2011","unstructured":"Diringer MN, Bleck TP, Claude Hemphill J, et al. Critical care management of patients following aneurysmal subarachnoid hemorrhage: recommendations from the Neurocritical Care Society\u2019s multidisciplinary consensus conference. Neurocrit Care. 2011;15:211\u201340.","journal-title":"Neurocrit Care"},{"key":"1466_CR13","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.1161\/STR.0b013e3182587839","volume":"43","author":"ES Connolly Jr","year":"2012","unstructured":"Connolly ES Jr, Rabinstein AA, Carhuapoma JR, et al. Guidelines for the management of aneurysmal subarachnoid hemorrhage: a guideline for healthcare professionals from the American Heart Association\/American Stroke Association. Stroke. 2012;43:1711\u201337.","journal-title":"Stroke"},{"key":"1466_CR14","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1159\/000346087","volume":"35","author":"T Steiner","year":"2013","unstructured":"Steiner T, Juvela S, Unterberg A, Jung C, Forsting M, Rinkel G. European Stroke Organization guidelines for the management of intracranial aneurysms and subarachnoid haemorrhage. Cerebrovasc Dis. 2013;35:93\u2013112.","journal-title":"Cerebrovasc Dis"},{"key":"1466_CR15","doi-asserted-by":"publisher","first-page":"117313","DOI":"10.1016\/j.jns.2021.117313","volume":"421","author":"M Angermann","year":"2021","unstructured":"Angermann M, Jablawi F, Keulers A, et al. Posterior reversible encephalopathy syndrome after induced hypertension therapy for delayed cerebral ischemia after subarachnoid hemorrhage: A case-control study. J Neurol Sci. 2021;421:117313.","journal-title":"J Neurol Sci"},{"key":"1466_CR16","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1111\/ijs.12055","volume":"9","author":"CS Gathier","year":"2014","unstructured":"Gathier CS, van den Bergh WM, Slooter AJ. HIMALAIA (Hypertension Induction in the Management of AneurysmaL subArachnoid haemorrhage with secondary IschaemiA): a randomized single-blind controlled trial of induced hypertension vs. no induced hypertension in the treatment of delayed cerebral ischemia after subarachnoid hemorrhage. Int J Stroke. 2014;9:375\u201380.","journal-title":"Int J Stroke"},{"key":"1466_CR17","doi-asserted-by":"publisher","first-page":"3277","DOI":"10.1161\/STROKEAHA.115.010537","volume":"46","author":"CS Gathier","year":"2015","unstructured":"Gathier CS, Dankbaar JW, van der Jagt M, et al. Effects of induced hypertension on cerebral perfusion in delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage: a randomized clinical trial. Stroke. 2015;46:3277\u201381.","journal-title":"Stroke"},{"key":"1466_CR18","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1161\/STROKEAHA.117.017956","volume":"49","author":"CS Gathier","year":"2018","unstructured":"Gathier CS, van den Bergh WM, van der Jagt M, et al. Induced hypertension for delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage: a randomized clinical trial. Stroke. 2018;49:76\u201383.","journal-title":"Stroke"},{"key":"1466_CR19","doi-asserted-by":"publisher","first-page":"2630","DOI":"10.1161\/STROKEAHA.118.022310","volume":"49","author":"NM Haegens","year":"2018","unstructured":"Haegens NM, Gathier CS, Horn J, Coert BA, Verbaan D, van den Bergh WM. Induced hypertension in preventing cerebral infarction in delayed cerebral ischemia after subarachnoid hemorrhage. Stroke. 2018;49:2630\u20136.","journal-title":"Stroke"},{"key":"1466_CR20","doi-asserted-by":"publisher","first-page":"762","DOI":"10.3390\/jcm10040762","volume":"10","author":"J de Winkel","year":"2021","unstructured":"de Winkel J, van der Jagt M, Lingsma HF, et al. International practice variability in treatment of aneurysmal subarachnoid hemorrhage. J Clin Med. 2021;10:762.","journal-title":"J Clin Med"}],"container-title":["Neurocritical Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12028-022-01466-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12028-022-01466-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12028-022-01466-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,16]],"date-time":"2022-05-16T19:31:21Z","timestamp":1652729481000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12028-022-01466-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,8]]},"references-count":20,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,6]]}},"alternative-id":["1466"],"URL":"https:\/\/doi.org\/10.1007\/s12028-022-01466-7","relation":{},"ISSN":["1541-6933","1556-0961"],"issn-type":[{"value":"1541-6933","type":"print"},{"value":"1556-0961","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,8]]},"assertion":[{"value":"10 November 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 January 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 March 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"There are no conflicts of interest to report.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of Interest"}},{"value":"The study was conducted in accordance with the recommendations of the ethics committee of the Medical Faculty of the RWTH Aachen University (EK 062\/14).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval\/informed consent"}},{"value":"The prospective data collection was registered on May 20, 2014, at ClinicalTrials.gov (NCT02142166) as part of a larger scale prospective data collection.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical trial registration"}}]}}